Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price.
Tibor Markus Brunt, Amanda Marie Atkinson, Thomas Nefau, Magali Martinez, Emmanuel Lahaie, Artur Malzcewski, Martin Pažitný, Vendula Belackova, Simon D Brandt
The International journal on drug policy June 1, 2017 DOI: 10.1016/j.drugpo.2017.03.006 (opens in new tab) via PubMed
Summary
AI-generated from the abstractNew psychoactive substances purchased from European webshops vary widely in purity and are often mislabeled. Chemical analysis of around 10 substances per country from France, the UK, the Netherlands, the Czech Republic, and Poland found that purity differed considerably from the >99% typically advertised. Some products contained chemical analogues (e.g., 25B/C-NBOMe instead of 25I-NBOMe), and others differed substantially from what was advertised (e.g., pentedrone instead of AMT). Purity-adjusted prices of cathinones were lowest in Poland; synthetic cannabinoids were most expensive in the Czech Republic and least expensive in the UK. Mislabelling poses a potential danger, and price and purity variation may reflect market dynamics and law enforcement differences.
Study at a glance
| Characteristics | Observational chemical analysis Peer reviewed |
|---|---|
| Population | New psychoactive substances purchased from online webshops in five European Union countries |
| Keywords | Chemical analysis European union Nps Price Purity |
| Key finding | Purity of NPS purchased from European webshops varied considerably and was often lower than advertised; several products were mislabeled, sometimes with substantially different substances. |
Abstract
New psychoactive substances (NPS) are on offer worldwide online, in order to shed light on the purity and price of these substances in the European Union, a research collaboration was set up involving France, United Kingdom (UK), the Netherlands, Czech Republic and Poland. Per country, around 10 different NPS were test purchased from different webshops. Then, chemical analysis of NPS was done with according reference standards to identify and quantify the contents. In contrast to what is generally advertised on the webshops (>99%), purity varied considerably per test purchased NPS. Several NPS were mislabelled, some containing chemical analogues (e.g. 25B/C-NBOMe instead of 25I-NBOMe, pentedrone instead of 3,4-DMMC). But in some cases NPS differed substantially from what was advertised (e.g. pentedrone instead of AMT or 3-FMC instead of 5-MeO-DALT). Per gram, purity-adjusted prices of cathinones differed substantially between three countries of test purchase, with Poland being the least expensive. Synthetic cannabinoids were relatively the most expensive in the Czech Republic and least expensive in the UK. The current findings provides a snapshot of the price and chemical contents of NPS products purchased by different countries and in different webshops. There is a potential danger of mislabelling of NPS. The great variety in price and purity of the delivered products might be the result of the market dynamics of supply and demand and the role of law enforcement in different European countries.